Analysis of reverse acceptor control in mitochondria.
D000227:Adenine Nucleotides / Q000378:metabolism; D000244:Adenosine Diphosphate / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008353:Mannitol / Q000494:pharmacology; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D008933:Mitochondrial Swelling / Q000187:drug effects; D009243:NAD / Q000378:metabolism*; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction; D010539:Permeability; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology; D013053:Spectrophotometry
D000227:Adenine Nucleotides; D009243:NAD; D008353:Mannitol; D012965:Sodium Chloride; D004533:Egtazic Acid; D009249:NADP; D000244:Adenosine Diphosphate; D004492:Edetic Acid; D008274:Magnesium; D011188:Potassium; D002118:Calcium